Researchers at Spain’s University of Valladolid, BIOFORGE Labs, the SFI Research Center and CÚRAM have created a hydrogel injectable that may prevent additional damage and assist in repairing heart muscles following a heart attack.
Heart disease, or myocardial infarction, is the most common cause of death owing to irreversible damage of cardiac tissue after a heart attack. As tissue regeneration is minimal, any damage to heart muscle can’t be self-repaired. Present-day treatments lack an efficacious&
NOTE TO INVESTORS: The latest news and updates relating to MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) are available in the company’s newsroom at https://ibn.fm/MGROF
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.